Format

Send to

Choose Destination
See comment in PubMed Commons below
Actas Esp Psiquiatr. 2011 Sep-Oct;39(5):334-6. Epub 2011 Sep 1.

Effect of raloxifene (a Selective Estrogen Receptor Modulator (SERM)) as coadjuvant to antidepressant treatment: a case report.

Author information

1
Sant Joan de Déu-SSM, Fundació Sant Joan de Déu, Sant Boi, Barcelona. usall@sjd-ssm.com

Abstract

We report a case of a woman with a depressive disorder with partial response to antidepressant treatment. Raloxifene, a Selective Estrogen Receptor Modulator (SERM) was added to the treatment, the patient achieving complete remission of her depressive symptoms. The interest of our case lies in the fact that it exemplifies the relationship between depressive disorders and hormonal changes during menopause. Furthermore, raloxifene may become a novel therapeutic option in some postmenopausal women who do not respond or only partially respond to SSRIs, especially in those with a history of depressive disorders related to menopause.

PMID:
21953363
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for International Foundation Juan Jose Lopez Ibor
    Loading ...
    Support Center